Biocon raises ₹4,500 crore through QIP, its first equity issue since IPO, to fund innovation, repay debt, and expand global ...

Biocon, a leading biopharmaceutical company, successfully raised Rs 4,500 crore through QIP. This marks their first equity ...

Moody’s Ratings has affirmed Goldman Sachs BDC, Inc.’s (NYSE: GSBD) Baa3 long-term issuer and senior unsecured debt ratings, along with its (P)Baa3 senior uns ...

U.S. power was built on ‘bonds, barrels and bombs,” but that’s changing, says Goldman’s former commodity chief.

U.S. equities investors are reluctant to seek safety amid flaring geopolitical tensions, raising the risk of getting caught ...

MBK is ready to walk away from the Home Plus investment empty-handed, although it poured billions of dollars to take over the ...

In an exclusive interview with D CEO, the former head of the Dallas Fed and current Goldman Sachs vice chair also says ...

The so-called SPAC king, who created a dozen special-purpose acquisition companies that ultimately lost investors billions of dollars, says he's probably getting back in the business.

Goldman Sachs said markets are estimating a 65% likelihood of the U.S. intervening in the Middle East, though added there's a ...

Between 1933 and 2020, a period covering 14 presidents, economic growth has averaged 4.6% under Democrats as compared to 2.4% ...

GVIP tracks hedge fund favorites via 13F data and has outperformed in 2025, but strategy risks and timing concerns remain.